| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/11/2010 | WO2010016686A2 Nanoemulsion for local administration |
| 02/11/2010 | WO2010016581A1 Ultrasonic cancer therapy accelerator |
| 02/11/2010 | WO2010016509A1 Stable pharmaceutical composition containing tranexamic acid and ascorbic acid |
| 02/11/2010 | WO2010016219A1 External preparation comprising fatty acid salt or benzoic acid salt of basic pharmacologically active component, and method for production thereof |
| 02/11/2010 | WO2010016088A1 Topical intranasal composition usable in the case of nasal obstruction |
| 02/11/2010 | WO2010015939A1 Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack |
| 02/11/2010 | WO2010015911A1 Sustained release pharmaceutical compositions of ropinirole and process for preparation thereof |
| 02/11/2010 | WO2010015840A1 Osmotic delivery device with modified release |
| 02/11/2010 | WO2010015818A1 Respiratory disease treatment |
| 02/11/2010 | WO2010015800A1 Chewable formulation comprising alginate, bicarbonate and carbonate |
| 02/11/2010 | WO2010015754A1 Pharmaceutical composition in granule form and method for the production of such a pharmaceutcal composition |
| 02/11/2010 | WO2010015718A1 Treatment of vaginal atrophy in women with tumor pathology risk |
| 02/11/2010 | WO2010015713A1 Progestin-containing drug delivery system |
| 02/11/2010 | WO2010015709A2 Fibrous surface structure containing active ingredients with controlled release of active ingredients, use thereof and method for the production thereof |
| 02/11/2010 | WO2010015688A1 Oral formulations of chemotherapeutic agents |
| 02/11/2010 | WO2010015665A2 Compounds and methods |
| 02/11/2010 | WO2010015581A1 Production of beadlets comprising hygroscopic plant extracts |
| 02/11/2010 | WO2010015567A2 Controlled release formulations using intelligent polymers |
| 02/11/2010 | WO2010015419A2 Continuous fiber layer comprising an active substance on the basis of bio-polymers, the use thereof, and method for the production thereof |
| 02/11/2010 | WO2010015400A2 Injectable taxane pharmaceutical composition |
| 02/11/2010 | WO2010015298A2 Crystalline active ingredient microparticles, method for producing the same and use thereof in drugs |
| 02/11/2010 | WO2009129300A3 Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas |
| 02/11/2010 | WO2009003125A8 Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs |
| 02/11/2010 | US20100036084 Biodegradable poly(beta-amino esters) and uses thereof |
| 02/11/2010 | US20100035995 Compositions comprising Cyclohexylamines and Aminoadamantanes |
| 02/11/2010 | US20100035928 Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate |
| 02/11/2010 | US20100035854 Dry powder formulations |
| 02/11/2010 | US20100034959 High solids, high molecular weight polymer coating |
| 02/11/2010 | US20100034910 Spray drying process control of drying kinetics |
| 02/11/2010 | US20100034896 Self-assembling nanoparticles composed of transmembrane peptides and their application for specific intra-tumor delivery of anti-cancer drugs |
| 02/11/2010 | US20100034895 Methods of treatment using a gastric retained gabapentin dosage |
| 02/11/2010 | US20100034894 Use of Sucralose as a Granulating Agent |
| 02/11/2010 | US20100034892 Treatment for bone formation disorders by growth factor delivery |
| 02/11/2010 | US20100034891 Taste-masking solid preparation of pioglitazone |
| 02/11/2010 | US20100034890 Combinations of formoterol and fluticasone propionate for asthma |
| 02/11/2010 | US20100034889 Effervescent tablets/granules |
| 02/11/2010 | US20100034888 Granulate containing a pharmaceutically active substance and method for its manufacture |
| 02/11/2010 | US20100034887 Bursting Pellets |
| 02/11/2010 | US20100034886 Polyglutamic Acids Functionalised by Histidine Derivatives and Hydrophobic Groups and the Uses Thereof, in Particular for Therapeutic Purposes |
| 02/11/2010 | US20100034885 Formulations containing glimepiride and/or its salts |
| 02/11/2010 | US20100034884 Luminescent conducting nano-drug crystal ultra-thin film self-assembly and uses |
| 02/11/2010 | US20100034883 Light-curable bone growth material for treating dental bone defects |
| 02/11/2010 | US20100034882 Silver-containing compositions, devices and methods for making |
| 02/11/2010 | US20100034881 Macromolecular diffusion and release from self-assembled beta-hairpin peptide hydrogels |
| 02/11/2010 | US20100034880 Pharmaceutical compositions based on a microemulsion |
| 02/11/2010 | US20100034879 Hyaluronic acid product and method for treating lacerations and wounds in a living body |
| 02/11/2010 | US20100034878 Combination of vitamin k and vitamin k antagonist such as r-isomer of warfarin, phenprocoumon or r-isomer of phenprocoumon as anticoagulant therapy |
| 02/11/2010 | US20100034877 Use of lactobacillus for treatment of virus infections |
| 02/11/2010 | US20100034876 Controlled release oxycodone compositions |
| 02/11/2010 | US20100034875 Immunogenic compositions and methods of use |
| 02/11/2010 | US20100034874 Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome |
| 02/11/2010 | US20100034873 Transdermal ricinoleic acid compositions |
| 02/11/2010 | US20100034871 Center-Filled Chewing Gum Product For Dental Care |
| 02/11/2010 | US20100034869 Block-polymer membranes for attenuation of scar tissue |
| 02/11/2010 | US20100034866 Fused stem cells useful for the treatment of diabetes and methods thereof |
| 02/11/2010 | US20100034865 Osteoinductive calcium phosphates |
| 02/11/2010 | US20100034864 Stem cell capture and immobilization coatings for medical devices and implants |
| 02/11/2010 | US20100034863 Delivery Devices Containing Encapsulated and/or Particle-Bound Active Pharmaceutical Ingredients |
| 02/11/2010 | US20100034862 Covalently grafted pharmaceutically active polymers |
| 02/11/2010 | US20100034861 Dispersions of nanoureas comprising biologically active compounds |
| 02/11/2010 | US20100034860 Intra-Oral Device for Treating Obesity |
| 02/11/2010 | US20100034859 Method for making an implantable biocompatible material with mixed Pseudo-crystalline lattice and material obtainable by said method |
| 02/11/2010 | US20100034754 Method for making insect repellent composition |
| 02/11/2010 | US20100034753 Edible foam product for the treatment or prevention of obesity |
| 02/11/2010 | US20100034752 Inhalant formulations comprising a bisphosphonate and a pyrazolone derivative and methods for using the same |
| 02/11/2010 | US20100034749 Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases |
| 02/11/2010 | US20100034735 Targeted nanoparticles for cancer diagnosis and treatment |
| 02/11/2010 | US20100034696 Ciclesonide-containing sterile aqueous suspension |
| 02/11/2010 | DE102008037025A1 Kristalline Wirkstoff-Mikropartikel, Verfahren zu deren Herstellung und Verwendung in Arzneimitteln Crystalline drug microparticles, methods for their preparation and use in medicaments |
| 02/11/2010 | CA2733440A1 Respiratory disease treatment |
| 02/11/2010 | CA2733252A1 Medical devices for use in the surgical treatment of hyperproliferative diseases affecting the spinal cord |
| 02/11/2010 | CA2733237A1 Oral formulations of chemotherapeutic agents |
| 02/11/2010 | CA2733149A1 Use of dronedarone for the preparation of a medicament for the prevention of stroke or transient ischemic attack |
| 02/11/2010 | CA2733147A1 Microparticles for use in immunogenic compositions |
| 02/11/2010 | CA2732952A1 Crystalline microparticles of an active substance, method for producing the same and use thereof in medicaments |
| 02/11/2010 | CA2732901A1 Injectable taxane pharmaceutical composition |
| 02/11/2010 | CA2732877A1 Treatment of vaginal atrophy in women with tumor pathology risk |
| 02/11/2010 | CA2732785A1 Compounds and methods |
| 02/11/2010 | CA2732777A1 Pharmaceutical formulations of an hcv protease inhibitor in a solid molecular dispersion |
| 02/11/2010 | CA2732356A1 Fast onset orodispersable tablets |
| 02/11/2010 | CA2732211A1 Progestin-containing drug delivery system |
| 02/11/2010 | CA2732105A1 Use of sucralose as a granulating agent |
| 02/11/2010 | CA2732093A1 Controlled release formulations using intelligent polymers |
| 02/11/2010 | CA2731180A1 Effervescent tablets/granules |
| 02/11/2010 | CA2729972A1 Lyophilization above collapse |
| 02/10/2010 | EP2151466A1 Biologically active silicic acid |
| 02/10/2010 | EP2151252A2 Solid film, rapidly dissolvable in liquids |
| 02/10/2010 | EP2151247A1 Solid dialysis preparation |
| 02/10/2010 | EP2151241A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative |
| 02/10/2010 | EP2151239A1 A kind of hydrochloric piperphentonamine freeze-dried powder injection, preparation methods and uses thereof |
| 02/10/2010 | EP2151235A1 Pharmaceutical formulation for treating the upper digestive tract |
| 02/10/2010 | EP2151234A1 Pharmaceutical formulation comprising a CB1-receptor compound in a solid solution and/or solid dispersion |
| 02/10/2010 | EP2150537A2 High temperature stable peptide formulation |
| 02/10/2010 | EP2150264A1 Stabilization of liquid solutions of recombinant protein for frozen storage |
| 02/10/2010 | EP2150245A1 Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins |
| 02/10/2010 | EP2150243A2 Compositions and methods for enhancing active agent absorption |
| 02/10/2010 | EP2150242A2 Pharmaceutical compositions of duloxetine |
| 02/10/2010 | EP2150241A1 Sustained release microtablets comprising tolterodine tartrate |
| 02/10/2010 | EP2150240A1 Pharmaceutical composition exhibiting improved stability comprising ace inhibitor or pharmaceutically acceptable salt thereof and method for manufacturing thereof |
| 02/10/2010 | EP2150239A1 Combination with an extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof |